Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms

Beta-lactam/beta-lactamase inhibitor combination antimicrobials (BLBLIs) are among the most controversial classes of antibiotic agents available for the treatment of infections caused by extended-spectrum-beta-lactamase (ESBL)-producing Gram-negative bacteria (ESBL-GNR). Piperacillin-tazobactam (PTZ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Microbiol
Autors principals: Schuetz, Audrey N., Reyes, Sergio, Tamma, Pranita D.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2018
Matèries:
Point-Counterpoint
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824049/
https://ncbi.nlm.nih.gov/pubmed/29237787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01917-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars